Tags

Type your tag names separated by a space and hit enter

A sequential double blind cross-over trial of tocainide hydrochloride in tinnitus.
Clin Otolaryngol Allied Sci. 1985 Apr; 10(2):97-101.CO

Abstract

A sequential double blind cross-over trial of tocainide hydrochloride, an oral analogue of lignocaine, is reported. The dosage of tocainide hydrochloride ranged from 200-600 mg daily. Of the 32 patients who completed the trial, 1 had complete relief and 2 had partial relief of their tinnitus whilst taking tocainide. An increased incidence of side-effects in patients taking tocainide was noted, in particular, headache, dizziness, nausea and skin rashes.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

3928215

Citation

Blayney, A W., et al. "A Sequential Double Blind Cross-over Trial of Tocainide Hydrochloride in Tinnitus." Clinical Otolaryngology and Allied Sciences, vol. 10, no. 2, 1985, pp. 97-101.
Blayney AW, Phillips MS, Guy AM, et al. A sequential double blind cross-over trial of tocainide hydrochloride in tinnitus. Clin Otolaryngol Allied Sci. 1985;10(2):97-101.
Blayney, A. W., Phillips, M. S., Guy, A. M., & Colman, B. H. (1985). A sequential double blind cross-over trial of tocainide hydrochloride in tinnitus. Clinical Otolaryngology and Allied Sciences, 10(2), 97-101.
Blayney AW, et al. A Sequential Double Blind Cross-over Trial of Tocainide Hydrochloride in Tinnitus. Clin Otolaryngol Allied Sci. 1985;10(2):97-101. PubMed PMID: 3928215.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A sequential double blind cross-over trial of tocainide hydrochloride in tinnitus. AU - Blayney,A W, AU - Phillips,M S, AU - Guy,A M, AU - Colman,B H, PY - 1985/4/1/pubmed PY - 1985/4/1/medline PY - 1985/4/1/entrez SP - 97 EP - 101 JF - Clinical otolaryngology and allied sciences JO - Clin Otolaryngol Allied Sci VL - 10 IS - 2 N2 - A sequential double blind cross-over trial of tocainide hydrochloride, an oral analogue of lignocaine, is reported. The dosage of tocainide hydrochloride ranged from 200-600 mg daily. Of the 32 patients who completed the trial, 1 had complete relief and 2 had partial relief of their tinnitus whilst taking tocainide. An increased incidence of side-effects in patients taking tocainide was noted, in particular, headache, dizziness, nausea and skin rashes. SN - 0307-7772 UR - https://www.unboundmedicine.com/medline/citation/3928215/A_sequential_double_blind_cross_over_trial_of_tocainide_hydrochloride_in_tinnitus_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0307-7772&date=1985&volume=10&issue=2&spage=97 DB - PRIME DP - Unbound Medicine ER -